Denali Therapeutics Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$27.64 | $1.59 B | -7.1 | 63 | $0 |
APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.13 | $291.95 M | -3.13 | 24 | $0 |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
FDMT
4D Molecular Therapeutics, Inc. |
$6.35 | $1.17 B | -9.63 | 147 | $37,000 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.62 | $151.66 M | -3.17 | 46 | $1.89 M |
IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
LEGN
Legend Biotech Corporation |
$34.72 | $8.31 B | -17.66 | 2600 | $627.24 M |
PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
RNA
Avidity Biosciences, Inc. |
$31.42 | $2.54 B | -8.99 | 391 | $10.90 M |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
SWTX
SpringWorks Therapeutics, Inc. |
$38.86 | $2.98 B | -7.81 | 368 | $191.59 M |
TVTX
Travere Therapeutics, Inc. |
$18.71 | $542.80 M | -1.32 | 385 | $233.18 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
